Very few new mental health treatments have been licensed and made available in the past decade. Our mental health theme aims to accelerate the translation of novel interventions and markers that support diagnosis and personalisation of treatment to late phase trials within the NHS.
We will do this by:
- routine deep phenotyping (comprehensive analysis of traits)
- large-scale patient data collection
- driving delivery of early-phase trials
- supporting the next generation of leaders in experimental medicine for mental health.
Our mental health theme is linked closely with UCL’s newly established Institute of Mental Health and Camden and Islington NHS Trust, and brings together psychiatrists, psychologists, pharmacists, neurosurgeons, engineers, data scientists and the UK’s largest single university group of preclinical neuroscientists, in collaborations focused on early translation.
A dedicated mental health theme embedded within a large BRC and multi-faculty university brings benefits. With the high ranking of UCL neuroscience and the scale and quality of partner NHS services, our translational mental health research capacity are forefront .
Our strategy focuses on health informatics, development of new treatments and precision medicine for mental health.